Develops drugs for mental health conditions.
Jun 2026Revenue $1.67B/yrExpenses $1.55B/yr
No trend
Figures by year
Is Alkermes profitable?
Yes. In the 12 months to Jun 2026, revenue was $1.67B and expenses $1.55B.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $1.48B | $1.22B | $254M |
| Dec 2024 | $1.56B | $1.14B | $421M |
| Dec 2023 | $1.66B | $1.25B | $414M |
| Dec 2022 | $1.11B | $1.12B | −$6.09M |
| Dec 2021 | $1.17B | $1.08B | $97.7M |
| Dec 2020 | $1.04B | $1.15B | −$112M |
| Dec 2019 | $1.17B | $1.35B | −$175M |
| Dec 2018 | $1.09B | $1.19B | −$99.1M |
| Dec 2017 | $903M | $1.05B | −$148M |
| Dec 2016 | $746M | $954M | −$209M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.